Heatstroke Treatment Market Size, Global Industry Growth, Statistics, Trends, Revenue Analysis 2020 | Mankind Pharma, Eagle Pharmaceuticals, Medisim, Novartis AG, Johnson & Johnson, Abbott

Research and analysis about the key developments in the market, major competitors and detailed competitor analysis covered in this Heatstroke Treatment Market report helps businesses imagine the bigger picture of the market place & products which ultimately assists in defining superior business strategies. This report also provides notable data, present market trends, future events, market environment, technological innovation, forthcoming technologies and the technical advancement in the relevant industry. Heatstroke Treatment Market research report bestows clients with the best results and for the same it has been produced by using integrated approaches and latest technology.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-heatstroke-treatment-market&rp

The study conducted for Healthcare industry also analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors with the help of SWOT analysis and Porter's Five Forces Analysis. It all-inclusively estimates general market conditions, the growth prospects in the market, possible restrictions, significant industry trends, market size, market share, sales volume & future trends. This Heatstroke Treatment Market report has been prepared with the combination of steps which employs a nice blend of industry insights, practical solutions, & latest tools & technologies.

Market Analysis: Global Heatstroke Treatment Market

Global heatstroke treatment market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rising average Earth temperature due to global warming, all age groups are vulnerable to the exposure and increasing prevalence of heart and lung disorders, development in the healthcare expenditure and rise in investment from government, public & private organizations for the development of novel drugs are some of the factors fueling the market growth.

Key Market Players:

The key market players in the global heatstroke treatment market are Mankind Pharma, Eagle Pharmaceuticals, Inc, Otsuka Holdings Co. Ltd, Medisim, Takeda Pharmaceutical Company Limited, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services, Inc, Abbott, AstraZeneca, ALLERGAN, Patanjali Ayurved, Sun Pharmaceutical Industries Ltd among others.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-heatstroke-treatment-market&rp

 Report on Heatstroke Treatment market highlights : 

Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size
Recent industry trends
Key competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Market Definition: Global Heatstroke Treatment Market

Heatstroke is a condition which occurs when body temperature rises above 104 F or 40ºC in adults, and 105 F or 40.5ºC in children, as a result of prolonged exposure to sunlight or heat or physical exertion in high temperatures. Heatstroke requires emergency treatment as it quickly damages the brain tissues, heart, kidney and muscles. If the treatment is delayed the condition gets worseand increases the chances of serious complications or death. Symptoms include high body temperature, altered mental state or behavior, tachycardia, rapid breathing nausea, vomiting among others.

Heat stroke is a life-threatening condition and requires emergency treatment, from 2006 to 2010 about 3332 deaths were reported attributed to heatstroke in the USA, 58 and 71% mortality rates have been reported for 28-day and 2-year respectively regarding heatstroke. It has been reported that the number of deaths will increase due to climate change. By the year 2050, heat stroke-related deaths are expected to rise nearly 2.5 times from the current annual deaths of approximately 2000.

Segmentation: Global Heatstroke Treatment Market

Heatstroke Treatment Market : By Types

Exertional Heat Stroke
Non-Exertional Heat Stroke

Heatstroke Treatment Market : By Mechanism of Action

Antihistamines
Diuretics
Sedatives
Stimulants
Anticonvulsants
Vasoconstrictors
Others

Heatstroke Treatment Market : By Drugs

Dantrolene
Midazolam
Clonidine
Meperidine
Others

Heatstroke Treatment Market : By Diagnosis

Rectal Temperature
Blood Test
Urine Test
Muscle Function Test
Others

Heatstroke Treatment Market : By Treatment

Medication
Cold Therapy
Supportive Care

Heatstroke Treatment Market : By Route of Administration

Oral
Parenteral

Heatstroke Treatment Market : By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Heatstroke Treatment Market : By End-Users

Hospitals
Homecare
Specialty Clinics

Heatstroke Treatment Market : By Geography

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Key Developments in the Market :

In March 2017, Eagle Pharmaceuticals, Inc received the Priority Review designation for its novel drug Ryanodex (dantrolene sodium) for the treatment of exertional heat stroke (EHS) from the U.S FDA. There is currently no approved drug for the treatment of heatstroke. Ryanodex (dantrolene sodium) already received a fast track designation from the U.S FDA, these designations will help the company for early approval of this drug and if approved it will be the first drug therapy for EHS

In January 2017, Eagle Pharmaceuticals, Inc completed the New Drug Application (NDA) submission for Ryanodex (dantrolene sodium) to the U.S. FDA for the treatment of exertional heat stroke (EHS). There is currently no approved drug for the treatment of heatstroke and if this is drug approved it will offer a new standard of care for this serious and life-threatening condition

Heatstroke Treatment Market Drivers :

Rising average Earth temperature due to global warming has fueled the market growth

Increasing prevalence of heart and lung disorders is driving the market growth

Increasing military training and participating in sports, such as football or long-distance running events, in hot weather can lead to heatstroke; this factor further enhances the market growth

Heatstroke Treatment Market Restraints :

Lack of awareness and first aid knowledge amongst people about heatstroke is hampering the market growth

Unavailability of skilled professionals for emergency treatment related to heatstroke also acts as a market restraint

Lack of facilities and emergency departments in remote areas is hindering the market growth

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-heatstroke-treatment-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.